Exercise of Option & Director/PDMR Shareholding
CRH
€36.73
18:30 22/01/21
18 October 2024
Headlam Group plc
(the 'Company')
Director/PDMR shareholding
Exercise of option under the Headlam Group plc Deferred Bonus Plan and sale of shares
Headlam Group plc (LSE: HEAD), Europe's leading floorcoverings distributor, announces that on 17 October 2024, Chris Payne exercised his 2022 nil-cost option to purchase 46,827 ordinary shares of 5 pence each in the capital of the Company ('Shares') under the Company's Deferred Bonus Plan. The number of Shares under option reflects the addition of dividend equivalents in Shares, calculated on a reinvestment basis. Chris Payne subsequently sold 22,064 Shares to cover exercise costs (including tax and NI) arising on exercise and has 24,763 retained Shares.
46,827 ordinary shares of 5 pence each have been transferred from treasury stock for the purposes of satisfying the award. Following the above transfer of treasury stock, the Company holds 4,804,315 ordinary shares as treasury shares.
The total number of ordinary shares in issue (excluding shares held as treasury shares) is 80,834,894 with one voting right per share. Therefore, the total number of voting rights in the Company is 80,834,894. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Headlam Group plc | Tel: 01675 433 000 |
Chris Payne, Chief Executive | Email: [email protected] |
Adam Phillips, Chief Financial Officer
Alison Hughes, General Counsel & Company Secretary | |
Panmure Gordon (UK) Limited (Corporate Broker) | Tel: 020 7886 2500 |
Tom Scrivens / Atholl Tweedie
Peel Hunt LLP (Corporate Broker) |
Tel: 020 7418 8900 |
George Sellar / John Welch |
Notification and public disclosure of transactions by PDMRs and persons closely associated with them
1. | Details of PDMR / person closely associated with them ("PCA") | |||||
a) | Name | Chris Payne | ||||
2. | Reason for the notification
| |||||
a) | Position / status | Chief Executive | ||||
b) | Initial notification / amendment | Initial notification | ||||
3. | Details of the issuer | |||||
a) | Name | Headlam Group plc
| ||||
b) | LEI | 213800I4AZZUJEYX9O90 | ||||
4.1 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.05 each. | ||||
b) | Identification code | ISIN: GB0004170089 | ||||
c) | Nature of the transaction | Exercise of a nil-cost option under the Company's Deferred Bonus Plan | ||||
d) | Price(s) and volume(s) |
| ||||
e) | Aggregated information - Volume - Price | N/A | ||||
f) | Date of the transaction | 17 October 2024 | ||||
g) | Place of the transaction | Outside a trading venue | ||||
4.2 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.05 each. | ||||
b) | Identification code | ISIN: GB0004170089 | ||||
c) | Nature of the transaction | Sale of shares to cover costs of the exercise of a nil-cost option outlined in 4.1 (including tax and NI liability) | ||||
d) | Price(s) and volume(s) |
| ||||
e) | Aggregated information - Volume - Price | N/A
N/A - Single Transaction N/A - Single Transaction | ||||
f) | Date of the transaction | 17 October 2024 | ||||
g) | Place of the transaction | London Stock Exchange - XLON | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.